Team Strategies for Overcoming Challenges to Guideline-Concordant Care of High-Risk HR-Positive/HER2-Negative Early Breast Cancer

Content Format:

Video

Credit Type:

AAPA | ABIM MOC | ACPE | AMA | ANCC | Pharmacotherapy Credit

Credits:

1.00
Guideline-Concordant Care of High-Risk HR-Positive/HER2-Negative Early Breast Cancer 

Content Format:

Slideset

Credit Type:

--

Credits:

--
ClinicalThought Expert Office Hours Forum: Navigating Treatment Decisions in High-Risk HR+/HER2- Early Breast Cancer

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Experts Highlight the Most Important Advances in HR+/HER2- Breast Cancer

Content Format:

Video

Credit Type:

ACPE | AMA

Credits:

1.00
Experts Highlight the Most Important Advances in HR+/HER2- Breast Cancer

Content Format:

Video

Credit Type:

ACPE | AMA

Credits:

1.00
Experts Highlight the Most Important Advances in HR+/HER2- Breast Cancer

Content Format:

Slideset

Credit Type:

--

Credits:

--
Expert Insights and FAQs on CDK4/6 Inhibitors in the Care of Today’s Patients With HR-Positive/HER2-Negative Breast Cancer

Content Format:

Podcast

Credit Type:

ABIM MOC | AMA

Credits:

0.75
Individualizing the Current Adjuvant Therapy Algorithm for Patients With HR+/HER2- EBC

Content Format:

Video

Credit Type:

ABIM MOC | AMA

Credits:

0.50
Individualizing Therapy for Patients With HR+/HER2- MBC

Content Format:

Video

Credit Type:

ABIM MOC | AMA

Credits:

0.50
Managing AEs With CDK4/6 Inhibitors to Promote Adherence and Persistence to Oral Therapy in Your Practice

Content Format:

Video

Credit Type:

ABIM MOC | AMA

Credits:

0.50
Individualizing Therapy for Patients With HR+/HER2- MBC

Content Format:

Slideset

Credit Type:

ABIM MOC | AMA

Credits:

0.50
(Neo) Adjuvant Therapy in HER2-Negative Early Breast Cancer Treatment Selection Tool

Content Format:

Tool

Credit Type:

--

Credits:

--
ExpressPoints: HER2-Positive Breast Cancer: A Guide Through an Evolving Treatment Landscape

Content Format:

Slideset

Credit Type:

--

Credits:

--
Expert Guidance on the Evolving Therapeutic Landscape for HER2-Positive Early-Stage Breast Cancer: Slides

Content Format:

Slideset

Credit Type:

--

Credits:

--